Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer

February 14, 2019, San Francisco, California

Please note that slides are for review only and not to be repurposed or published.

Introduction:
Dr Neil Love

MODULE 1:
Incorporation of Androgen Receptor Antagonists into the Management of M0 Prostate Cancer (PC) — Dr Smith

MODULE 2:
Management of Metastatic Hormone-Sensitive PC (mHSPC) — Dr Sternberg

MODULE 3:
Current and Future Management of Metastatic CRPC (mCRPC) — Dr Scher

MODULE 4:
Biologic Rationale for and Ongoing Evaluation of PARP Inhibitors in the Management of mPC — Dr Antonarakis

MODULE 5:
Bone-Targeted Therapies and Other Emerging Radiopharmaceuticals — Dr Sartor

Live Poll Results
Download